Disposition of orally administered atuliflapon, a novel 5-lipoxygenase-activating protein inhibitor in healthy participants
健康受试者口服新型5-脂氧合酶激活蛋白抑制剂阿图利芬的体内分布
期刊:Pharmacology Research & Perspectives
影响因子:2.3
doi:10.1002/prp2.70029
Li, Xue-Qing; Lindmark, Bo; Amilon, Carl; Samuelsson, Kristin; Weidolf, Lars; Nelander, Karin; Knöchel, Jane; Heijer, Maria; Bragg, Ryan A; Gränfors, Malin; Lindstedt, Eva-Lotte; Sidhu, Sharan; Garkaviy, Pavlo; Ericsson, Hans
